OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
90030057

Organic Tea Cosmetics Holdings Co Ltd

Personal ProductsVerified

The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative approach to leverage. With total equity of 1,428,561,290 CNY and total liabilities of 452,858,090 CNY, the firm maintains a strong equity base. Liquidity is robust, as evidenced by a current ratio of 3.39 and cash and equivalents of 227,452,580 CNY, which provides a buffer against short-term obligations. Profitability metrics are concerning, with a negative return on equity of -6.05% and a return on assets of -4.59%. These figures suggest the company is not generating returns that meet the cost of capital or asset efficiency benchmarks. The operating loss of 53,723,960 CNY and net loss of 86,401,870 CNY further underscore the financial challenges. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to market-specific risks and limits the ability to offset performance shortfalls in one area with gains in another. Growth trajectory appears negative, with the company reporting a net loss and negative operating cash flow of -41,655,670 CNY. Analyst estimates for revenue and EPS are significantly higher than the reported figures, suggesting a potential disconnect between market expectations and actual performance. The negative free cash flow of -85,092,660 CNY indicates the company is not generating sufficient cash to fund operations or growth without external financing. Risk factors include liquidity and dilution risks, both of which are currently assessed as low. However, the negative operating and free cash flows suggest potential future liquidity pressures. No immediate filing-based dilution flags were detected, but the company's financial performance could necessitate equity issuance in the future. Recent events include the latest financial filing, which shows a significant revenue figure of 240,030,000,000 CNY and an EPS of 7,740.00 CNY. These figures are notably higher than the reported revenue of 233,312,540 CNY, indicating a potential discrepancy or a different reporting period.

30-day price · 900300+0.00 (+0.0%)
Low$97.00High$284.00Close$111.00As of17 May, 00:00 UTC
Profile
CompanyOrganic Tea Cosmetics Holdings Co Ltd
Ticker900300.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Organic Tea Cosmetics Holdings Co Ltd develops and sells personal care products, primarily leveraging organic and tea-based ingredients to target health-conscious consumers in the personal products market.

Classification. The company is classified under the Personal Products industry within the Personal & Household Products & Services business sector, with a high confidence level of 0.92 based on verified market data.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative approach to leverage. With total equity of 1,428,561,290 CNY and total liabilities of 452,858,090 CNY, the firm maintains a strong equity base. Liquidity is robust, as evidenced by a current ratio of 3.39 and cash and equivalents of 227,452,580 CNY, which provides a buffer against short-term obligations. Profitability metrics are concerning, with a negative return on equity of -6.05% and a return on assets of -4.59%. These figures suggest the company is not generating returns that meet the cost of capital or asset efficiency benchmarks. The operating loss of 53,723,960 CNY and net loss of 86,401,870 CNY further underscore the financial challenges. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to market-specific risks and limits the ability to offset performance shortfalls in one area with gains in another. Growth trajectory appears negative, with the company reporting a net loss and negative operating cash flow of -41,655,670 CNY. Analyst estimates for revenue and EPS are significantly higher than the reported figures, suggesting a potential disconnect between market expectations and actual performance. The negative free cash flow of -85,092,660 CNY indicates the company is not generating sufficient cash to fund operations or growth without external financing. Risk factors include liquidity and dilution risks, both of which are currently assessed as low. However, the negative operating and free cash flows suggest potential future liquidity pressures. No immediate filing-based dilution flags were detected, but the company's financial performance could necessitate equity issuance in the future. Recent events include the latest financial filing, which shows a significant revenue figure of 240,030,000,000 CNY and an EPS of 7,740.00 CNY. These figures are notably higher than the reported revenue of 233,312,540 CNY, indicating a potential discrepancy or a different reporting period.
Key takeaways
  • The company has a strong equity base and low leverage, but is currently unprofitable with negative returns on equity and assets.
  • Liquidity is robust, with a high current ratio and significant cash reserves, but negative operating and free cash flows indicate potential future liquidity challenges.
  • Revenue is concentrated in a single segment, increasing exposure to market-specific risks.
  • Analyst estimates suggest a significant gap between market expectations and actual performance, highlighting potential misalignment or reporting inconsistencies.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$233.3M
Gross profit$80.5M
Operating income-$53.7M
Net income-$86.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$41.7M
CapEx
Free cash flow-$85.1M
Total assets$1.88B
Total liabilities$452.9M
Total equity$1.43B
Cash & equivalents$227.5M
Long-term debt$35.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.77B$81.0M$46.1M$24.7M
FY-3$1.52B$95.3M$44.6M$66.6M
FY-2$1.18B-$333.3M-$495.3M-$469.7M
FY-1$965.4M-$402.2M-$433.6M-$420.3M
FY0$870.7M-$293.7M-$251.0M-$250.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.08B$1.85B$608.0M
FY-3$2.40B$2.15B$475.2M
FY-2$2.34B$1.97B$388.3M
FY-1$1.88B$1.43B$227.5M
FY0$1.66B$1.33B$382.0M
PeriodOCFCapExFCFSBC
FY-4$189.9M-$49.3M$24.7M
FY-3$581.5M$66.6M
FY-2$374.0M-$469.7M
FY-1-$41.7M-$420.3M
FY0-$186.9M-$250.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$233.3M-$53.7M-$86.4M-$85.1M
FQ-6$139.1M-$41.2M-$41.8M-$41.8M
FQ-5$206.8M-$119.8M-$110.9M-$110.9M
FQ-4$270.8M-$133.4M-$141.3M-$141.3M
FQ-3$254.0M$645.7k$43.1M$43.9M
FQ-2$157.3M-$48.8M-$47.2M-$47.0M
FQ-1$234.0M-$95.4M-$174.1M-$173.9M
FQ0$234.5M-$142.1M-$126.7M-$126.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.88B$1.43B$227.5M
FQ-6$1.81B$1.39B$684.0M
FQ-5$1.68B$1.38B$657.0M
FQ-4$1.65B$1.29B$776.6M
FQ-3$1.66B$1.33B$382.0M
FQ-2$1.61B$1.29B$740.7M
FQ-1$1.54B$1.19B$595.7M
FQ0$1.44B$1.06B$687.3M
PeriodOCFCapExFCFSBC
FQ-7-$41.7M-$85.1M
FQ-6$408.8M-$41.8M
FQ-5$253.3M-$110.9M
FQ-4$328.4M-$141.3M
FQ-3-$186.9M$43.9M
FQ-2$354.6M-$47.0M
FQ-1$237.5M-$173.9M
FQ0$332.1M-$112.4k-$126.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.43B
Net cash$192.3M
Current ratio3.4
Debt/Equity0.0
ROA-4.6%
ROE-6.0%
Cash conversion48.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
Metric900300Activity
Op margin-23.0%6.0% medp25 0.5% · p75 12.6%bottom quartile
Net margin-37.0%5.2% medp25 0.5% · p75 10.9%bottom quartile
Gross margin34.5%43.2% medp25 26.0% · p75 61.0%below median
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.0% medp25 -5.5% · p75 -1.3%
Debt / equity2.0%13.3% medp25 2.5% · p75 55.2%bottom quartile
Observations
IR observations
Last actual EPS7,740.00 CNY
Last actual revenue240,003,000,000 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 01:24 UTC#3cee29d1
Market quoteclose CNY 170.00 · shares 0.10B diluted
no public URL
2026-05-07 01:24 UTC#5ab1bc5c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 04:41 UTCJob: 7a5672fa